Does FTC Health Ads Guide Read Like Rulemaking, Ignore Court Decisions On Requiring RCTs?

“I'm not sure they shouldn’t have done a notice of proposed rulemaking,” says attorney Claudia Lewis. From previous guidance, “the FTC has taken it a step in the different direction that you need robust scientific evidence, in their mind robust scientific evidence means clinical data.”

• Source: Shutterstock

The US Federal Trade Commission expanded its expectations so much in its updated advertising guidance health care products the agency should’ve considered proposing a rulemaking, a food and drug regulation attorney suggests.

“There are a couple of issues that I have with that guidance document,” said Claudia Lewis, a partner at Venable LLP in Washington and

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation